NVSEF - Novartis AG (NVS) CEO Vasant Narasimhan on Q4 2021 Results - Earnings Call Transcript
Novartis AG (NVS) Q4 2021 Earnings Conference Call February 02, 2022, 08:00 ET Company Participants Samir Shah - Global Head, IR Vasant Narasimhan - CEO Marie-France Tschudin - President, Novartis Pharmaceuticals Susanne Schaffert - President, Novartis Oncology Harry Kirsch - CFO Richard Saynor - CEO, Sandoz John Tsai - Head, Global Drug Development & Chief Medical Officer Conference Call Participants Graham Parry - Bank of America Merrill Lynch Richard Parkes - BNP Paribas Laura Sutcliffe - UBS Andrew Baum - Citigroup Simon Baker - Redburn Kerry Holford - Berenberg Keyur Parekh - Goldman Sachs Group Wimal Kapadia - Sanford C. Bernstein & Co. Matthew Weston - Crédit Suisse Richard Vosser - JPMorgan Chase & Co. Emmanuel Papadakis - Deutsche Bank Mark Purcell - Morgan Stanley Florent Cespedes - Societe Generale Peter Welford - Jefferies Seamus Fernandez - Guggenheim Securities Presentation Operator Good morning and good afternoon. And welcome to the
For further details see:
Novartis AG (NVS) CEO Vasant Narasimhan on Q4 2021 Results - Earnings Call Transcript